Diabetes, Vol 49, Issue 12 1998-2006, Copyright © 2000 by American Diabetes Association

ARTICLES

Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice

K Fujihira, M Nagata, H Moriyama, H Yasuda, K Arisawa, M Nakayama, S Maeda, M Kasuga, K Okumura, H Yagita and K Yokono
Department of Geriatric Medicine, Kobe University School of Medicine, Japan.

A corpus of evidence suggests that T-helper type 1 (Th1)-dependent cellular immunity plays a pivotal role in the pathogenesis of autoimmune diabetes. This study was intended to find ways to prevent the development of NOD diabetes using a neutralizing anti-interleukin (IL)-12 antibody (C17.8) that inhibits Thl cell differentiation. When C17.8 was administered from 5 to 30 weeks of age, NOD mice exhibited suppression of both insulitis and diabetes. However, when C17.8 administration ceased at 15 weeks of age, 8 of 13 recipients showed diabetes at 30 weeks of age. These results suggest that IL-12 plays an important role not only in the development of effector cells but also in their activation. In contrast, when C17.8 was injected into 2-week-old female NOD mice for 6 consecutive days, all 16 recipients showed diabetes at 30 weeks of age, whereas 12 of 20 control mice became diabetic. This result suggests that depletion of endogenous IL-12 at a young age results in the enhancement of diabetes. Flow cytometric analysis indicated that activated memory T-cells were present in higher numbers after C17.8 treatment. Transfer of spleen cells from 15-week-old C17.8-treated NOD mice to NOD-scid mice resulted in an earlier onset and a higher incidence of diabetes. Furthermore, administration of C17.8 to 2-week-old NOD mice also resulted in a much earlier onset of diabetes. These results suggest that short-term treatment with anti-IL-12 antibody prohibits IL-2 production at a young age, which may influence the expansion and apoptosis of pathogenic T-cells, resulting in the acceleration of autoimmune diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-J. Zheng, S.-E. Lamhamedi-Cherradi, P. Wang, L. Xu, and Y. H. Chen Tumor Suppressor p53 Inhibits Autoimmune Inflammation and Macrophage Function Diabetes, May 1, 2005; 54(5): 1423 - 1428. [Abstract] [Full Text] [PDF]

				A. Hino, M.-N. Kweon, K. Fujihashi, J. R. McGhee, and H. Kiyono Pathological Role of Large Intestinal IL-12p40 for the Induction of Th2-Type Allergic Diarrhea Am. J. Pathol., April 1, 2004; 164(4): 1327 - 1335. [Abstract] [Full Text] [PDF]

				J. Liu and D. I. Beller Distinct Pathways for NF-{kappa}B Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains J. Immunol., May 1, 2003; 170(9): 4489 - 4496. [Abstract] [Full Text] [PDF]

				S. Gregori, N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini A 1{alpha},25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice Diabetes, May 1, 2002; 51(5): 1367 - 1374. [Abstract] [Full Text] [PDF]

				J. G. Mabley, P. Pacher, G. J. Southan, A. L. Salzman, and C. Szabo Nicotine Reduces the Incidence of Type I Diabetes in Mice J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 876 - 881. [Abstract] [Full Text] [PDF]